Netanyahu asks Teva Pharm to minimize job loss in Israel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Teva Pharma (TEVA) PT Raised to $17 at BofA/Merrill Lynch; Reiterates Underperform
December 15, 2017 7:44 AM ESTBofA/Merrill Lynch raised its price target on Teva Pharma (NYSE: TEVA) to $17.00 (from $11.00) while maintaining a Underperform rating following the company's announcement that it will reduce its cumulative spending (COGS + OpEx) by $3bn by end of 2019. Cuts are on a net... More
Cantor Fitzgerald Remains Sidelined on Teva Pharma (TEVA) Following Announced Restructuring Plan
December 14, 2017 8:18 AM ESTCantor Fitzgerald reiterated a Neutral rating and $10.00 price target on Teva Pharma (NYSE: TEVA) following the company's announced restructuring plan. The plan includes reducing its workforce by over 25%, reducing its cost base by $3B by the end of 2019, and suspending its... More
